SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS shares collapsed after second-quarter results and a reduced full-year outlook, with the Foot Locker acquisition amplifying margin pressure. The community is torn between dip buyers calling the stock deeply oversold and critics who blame the acquisition and see more downside, with many discussing a potential spinoff or activist push.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit's earnings beat was overshadowed by weaker-than-expected guidance, reigniting AI-disruption fears and triggering a sharp post-earnings selloff that dragged down other software names. Community reaction is split between value buyers seeing an overreaction and bears arguing AI is eating into the company's tax-prep moat.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as chatter swirls around founder Patrick Soon-Shiong teasing a trial that pairs Novartis' Pluvicto with an IL-15 therapy, reinforcing the Anktiva platform's immune-restoration narrative. The community is also energized by the sector-wide oncology buzz from the Moderna/Merck vaccine news and ongoing short-squeeze speculation.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom is drawing heavy options chatter around its upcoming earnings report, with traders split between bearish put flow and speculative call plays as the community debates the potential post-earnings move. Much of the conversation also circles ZM's Anthropic stake, with many viewing the stock as an indirect way to gain exposure to a possible Anthropic IPO.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

A massive F-15 Eagle Crest contract award is the catalyst, but the muted reaction has retail traders split, with some calling it a buying opportunity while skeptics argue it is only a ceiling contract with no guarantees and insist delivery execution remains the real problem.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive is surging after disclosing another large Bitcoin purchase, bringing its treasury past 21,000 BTC, with the CEO saying the Bitcoin bull market is just getting started. Retail traders are piling in amid talk of a potential short squeeze, with heavy buzz about high short interest and Strive outperforming other Bitcoin-treasury stocks.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Shares are surging after CEO Troy Wilson made his second major open-market stock purchase in a short span, a move the community is reading as an unmistakable vote of confidence on top of strong KOMZIFTI launch momentum and the Kyowa Kirin partnership. Traders are also focused on the unusually high short interest, all the insider buying, and the chance that the company becomes a buyout candidate with the frontline AML and solid-tumor data still ahead.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVDA is rebounding after a seven-session losing streak as the community focuses on the upcoming earnings report, with chatter split between expectations for a strong beat-and-raise and concerns over another sell-the-news reaction. OpenAI's Jalapeno chip reportedly outperforming Nvidia's Blackwell in third-party benchmarks adds a fresh talking point about custom silicon starting to encroach on Nvidia's GPU dominance.

NextDecade Corp. is a development company, which focuses on liquefied natural gas (LNG) export projects and associated pipelines. It develops and manages land-based and floating liquefied natural gas projects in the Gulf Coast with focus on the Rio Grande LNG. The company was founded by Kathleen Eishbrenner in 2010 and is headquartered in Houston, TX.

NextDecade Corporation

Community attention on NextDecade centers on its Rio Grande LNG project advancing toward first gas and Train 1 production while retail posters emphasize high short interest, recent insider buys, FERC progress on Train 6, and growing conviction that US LNG is a key beneficiary of Middle East supply disruptions and AI-driven power demand.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as traders square off over the latest rally, with bulls calling it a long-awaited turnaround while bears dismiss it as a short-lived, propped-up move before a dump. Community chatter focuses on potential catalysts tied to JasmyChain activity and JPYD speculation, plus persistent debates over delisting FUD and the project's credibility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm PR Newswire NEW YORK, Aug. 19, 2026 NEW YORK, Aug. 19, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain...

Here's Why Exelixis (EXEL) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Exelixis (EXEL) Securities Investigation Notice - Levi & Korsinsky

Exelixis (EXEL) Securities Investigation Notice - Levi & Korsinsky Exelixis (EXEL) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 17, 2026 Exelixis posted second-quarter revenue of approximately $628.7 million -- short of Wall Street consensus -- and shares sold off...

EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exelixis, Inc. (Exelixis or the Company) (NASDAQ: EXEL) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on...

EXEL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Exelixis (EXEL)

Exelixis (NASDAQ: EXEL) shares dropped in after-hours trading after the Company reported Q2 revenue of approximately $628.7 million, missing consensus estimates, and lowered and narrowed its full-year 2026 revenue outlook. If you suffered a loss on your Exelixis investment, you are encouraged to...

EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis

EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis PR Newswire NEW YORK, Aug. 11, 2026 Exelixis lowered and narrowed its...

Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL)

Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL) Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL) PR Newswire NEW YORK, Aug. 10, 2026 On May 5, 2026, Exelixis management...

EXEL Tops Q2 Earnings Estimates, Misses on Sales, Lowers '26 View

Exelixis beats EPS estimates but misses on revenues; cuts 2026 outlook as a slower-than-expected NET launch weighs on expectations.

Exelixis (EXEL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Exelixis (EXEL) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

$EXEL Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.85 up 25.00% YoY
• Reported revenue of $628.69M up 10.63% YoY
• Exelixis updated its fiscal year 2026 guidance, now projecting total revenues of $2.500 billion to $2.550 billion and net product revenues of $2.300 billion to $2.350 billion for the company.

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Exelixis Inc

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

Equity

Extremely Bullish Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Feed

News

Sentiment

Earnings

Fundamentals

Info

EXEL Exelixis Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest EXEL News